1. The U.S. Thrombosis and Hemostasis Centers pilot sites program

   • N. F. Dowling
   • M. G. Beckman
   • T. L. Ortel

   OriginalPaper 17 November 2006 Pages: 1 - 7

   

2. Streptokinase—the drug of choice for thrombolytic therapy

   • Adinarayana Kunamneni
   • Thaer Taleb Abed Abdelghani
   • Poluri Ellaiah

   OriginalPaper 17 November 2006 Pages: 9 - 23

   

3. Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study

   • Nazim Isma
   • Ellinor Johanssson
   • Bengt Lindblad

   OriginalPaper 22 December 2006 Pages: 25 - 30

4. Prevalence of Factor V 1691 G–A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients

   • Aydan Eroglu
   • Arzu Ulu
   • Nejat Akar

   OriginalPaper 15 November 2006 Pages: 31 - 34

5. Delay in invasive risk stratification of women with acute coronary syndrome is associated with worse outcomes

   • Mouaz Husayn Al-Mallah
   • Rasha N. Bazari
   • Sanjaya Khanal

   OriginalPaper 22 December 2006 Pages: 35 - 39

   

6. Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis

   • Xinkang Wang
   • Patricia L. Smith
   • William A. Schumacher

   OriginalPaper 17 November 2006 Pages: 41 - 49

   

7. Predictors and outcomes associated with gastrointestinal bleeding in patients with acute coronary syndromes

   • Mouaz Al-Mallah
   • Rasha N. Bazari
   • Michael P. Hudson

   OriginalPaper 22 December 2006 Pages: 51 - 55

8. Rationale for intracoronary administration of abciximab

   • Enrico Romagnoli
   • Francesco Burzotta
   • Filippo Crea

   OriginalPaper 09 December 2006 Pages: 57 - 63

9. Misuse of antithrombotic therapy in atrial fibrillation patients: frequent, pervasive and persistent

   • Luciana S. Fornari
   • Daniela Calderaro
   • Bruno Caramelli

   OriginalPaper 22 December 2006 Pages: 65 - 71

   

10. Myocardial infarction associated with thrombus formation in non-culprit coronary arteries

    • Bilal Boztosun
    • Emre Gurel
    • Ayhan Olcay

    OriginalPaper 17 November 2006 Pages: 73 - 75

    

11. Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case–control study in Italian subjects

    • Dora Fabbro
    • Giovanni Barillari
    • Giuseppe Damante

    OriginalPaper 13 December 2006 Pages: 77 - 78

12. Warfarin-Induced Vasculopathy

    • Richard C. Becker

    EditorialNotes 28 November 2006 Pages: 79 - 81